Amira Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- Amira Pharmaceuticals's estimated annual revenue is currently $3.6M per year.
- Amira Pharmaceuticals's estimated revenue per employee is $201,000
Employee Data
- Amira Pharmaceuticals has 18 Employees.
- Amira Pharmaceuticals grew their employee count by 0% last year.
Amira Pharmaceuticals's People
Name | Title | Email/Phone |
---|
Amira Pharmaceuticals Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $46.2M | 230 | 5% | N/A | N/A |
#2 | $43.8M | 218 | 21% | N/A | N/A |
#3 | $57.1M | 284 | 26% | N/A | N/A |
#4 | $24.5M | 122 | 3% | N/A | N/A |
#5 | $52.9M | 263 | 13% | N/A | N/A |
#6 | $24.7M | 123 | 13% | N/A | N/A |
#7 | $1.8M | 18 | 0% | $114.3M | N/A |
#8 | $7.2M | 36 | -20% | N/A | N/A |
#9 | $13.7M | 68 | -7% | N/A | N/A |
#10 | $7.6M | 39 | -13% | $123.9M | N/A |
What Is Amira Pharmaceuticals?
Amira Pharmaceuticals is a small molecule pharmaceutical company focused on the discovery and early development of new drugs to treat inflammatory disease. Our discovery team is building on unparalleled insights into bioactive lipid pathways and complex signaling processes controlling many conditions including asthma, chronic obstructive pulmonary disease, cardiovascular and fibrotic diseases.
keywords:N/AN/A
Total Funding
18
Number of Employees
$3.6M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Amira Pharmaceuticals News
Wild Rice Products Market Size, Outlook And Forecast | Moose Lake Wild Rice, SunWest Foods, Amira Nature Foods, Lundberg, Nature's Gourmet Foods...
... was the Vice President and Head of Development at Acerta Pharma, ... in 2005 as Executive Director of Biology at Amira Pharmaceuticals.
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $7.5M | 18 | -40% | N/A |
#2 | $2.4M | 18 | -33% | N/A |
#3 | $1.4M | 18 | -18% | N/A |
#4 | $1.4M | 18 | -10% | $406.5M |
#5 | $1.4M | 18 | -33% | $173M |